CTOs on the Move

FibroGen

www.fibrogen.com

 
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.fibrogen.com
  • 409 Illinois St
    San Francisco, CA USA 94158
  • Phone: 415.978.1200

Executives

Name Title Contact Details
Curtis Golston
Director IT Operations Profile

Funding

FibroGen raised $126.02M on 07/09/2016

Similar Companies

Well Health

WELL™ Health is upending the $3.5 trillion healthcare market by helping patients and administrators break free of antiquated communication practices. This 2021 Best in KLAS for Patient Outreach software provides medical organizations with a single command center that connects the many tools they use, transforming everyday interactions between patients and the doctor`s front office.

Century Care Ctr

Century Care Ctr is a Century, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.

California Choice

California Choice is a Orange, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthFrontier (Canada)

HealthFrontier (Canada), Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.